28 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
determined that each of Messrs. Thomas and Truitt qualify as an “audit committee financial expert” within the meaning of SEC regulations. This designation … statements on Form 10-K, consents for the use of audit reports and reference to the auditor as an expert in our registration statements and professional
8-K
EX-5.1
nqdqesksz2quanks3x
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
S-8
EX-5.1
3vk tmh70
2 Oct 20
Registration of securities for employees
5:19pm
S-8
EX-5.1
dk6gvr5qd9eysaxdk4qu
26 Jun 20
Registration of securities for employees
5:28pm
8-K
EX-10.3
5ddwqx7jeu 2g5b
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
p7z08frw 14
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
jutywpylj7thpvrl
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
k00lay2lc nvawsayi
6 Mar 20
Preliminary proxy related to merger
5:32pm
8-K
EX-99.1
meafiyox7dd1 g5
7 Aug 18
Zafgen Reports Second Quarter 2018 Operating and Financial Results
4:21pm